These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20495880)

  • 41. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
    Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
    Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New approach to cell lineage analysis in mammals using the Cre-loxP system.
    Sato M; Yasuoka Y; Kodama H; Watanabe T; Miyazaki JI; Kimura M
    Mol Reprod Dev; 2000 May; 56(1):34-44. PubMed ID: 10737965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation.
    Regan CP; Manabe I; Owens GK
    Circ Res; 2000 Sep; 87(5):363-9. PubMed ID: 10969033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A global double-fluorescent Cre reporter mouse.
    Muzumdar MD; Tasic B; Miyamichi K; Li L; Luo L
    Genesis; 2007 Sep; 45(9):593-605. PubMed ID: 17868096
    [TBL] [Abstract][Full Text] [Related]  

  • 47. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.
    Zhuo L; Theis M; Alvarez-Maya I; Brenner M; Willecke K; Messing A
    Genesis; 2001 Oct; 31(2):85-94. PubMed ID: 11668683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Labeling of hematopoietic stem and progenitor cells in novel activatable EGFP reporter mice.
    Gilchrist DS; Ure J; Hook L; Medvinsky A
    Genesis; 2003 Jul; 36(3):168-76. PubMed ID: 12872249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pink mouse reports the switch from red to green fluorescence upon Cre-mediated recombination.
    Hartwich H; Satheesh SV; Nothwang HG
    BMC Res Notes; 2012 Jun; 5():296. PubMed ID: 22697046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase.
    Danielian PS; Muccino D; Rowitch DH; Michael SK; McMahon AP
    Curr Biol; 1998 Dec; 8(24):1323-6. PubMed ID: 9843687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis.
    Zheng B; Zhang Z; Black CM; de Crombrugghe B; Denton CP
    Am J Pathol; 2002 May; 160(5):1609-17. PubMed ID: 12000713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line.
    Lewandoski M; Wassarman KM; Martin GR
    Curr Biol; 1997 Feb; 7(2):148-51. PubMed ID: 9016703
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of mice expressing Ins1 gene promoter driven CreERT recombinase for conditional gene deletion in pancreatic β-cells.
    Tamarina NA; Roe MW; Philipson L
    Islets; 2014; 6(1):e27685. PubMed ID: 25483876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reporter alleles that inform on differences in Cre recombinase expression.
    Klinger M; Chmura SA; Killeen N
    J Immunol; 2010 Jun; 184(11):6170-6. PubMed ID: 20427774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel pan-neuronal Cre-transgenic line for conditional ablation of genes in the nervous system.
    Banares S; Zeh K; Krajewska M; Kermer P; Baribault H; Reed JC; Krajewski S
    Genesis; 2005 May; 42(1):6-16. PubMed ID: 15828007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of EGFP expression by Cre-mediated excision in a new ROSA26 reporter mouse strain.
    Mao X; Fujiwara Y; Chapdelaine A; Yang H; Orkin SH
    Blood; 2001 Jan; 97(1):324-6. PubMed ID: 11133778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Cre knock-in mouse line on the Sickle tail locus induces recombination in the notochord and intervertebral disks.
    Abe K; Araki K; Tanigawa M; Semba K; Ando T; Sato M; Sakai D; Hiyama A; Mochida J; Yamamura K
    Genesis; 2012 Oct; 50(10):758-65. PubMed ID: 22522943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a transgenic mouse model using rat insulin promoter to drive the expression of CRE recombinase in a tissue-specific manner.
    Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
    Int J Pancreatol; 1999 Jun; 25(3):157-63. PubMed ID: 10453417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and characterization of transgenic mouse models for conditional gene knockout in the blood-brain and blood-CSF barriers.
    Crouthamel MH; Kelly EJ; Ho RJ
    Transgenic Res; 2012 Feb; 21(1):113-30. PubMed ID: 21538071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene therapy utilizing the Cre/loxP system selectively suppresses tumor growth of disseminated carcinoembryonic antigen-producing cancer cells.
    Goto H; Osaki T; Kijima T; Nishino K; Kumagai T; Funakoshi T; Kimura H; Takeda Y; Yoneda T; Tachibana I; Hayashi S
    Int J Cancer; 2001 Nov; 94(3):414-9. PubMed ID: 11745423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.